跳至主要内容
临床试验/JPRN-UMIN000009123
JPRN-UMIN000009123已完成未知

Inhibitory effect of azelnidipine on sympathetic nerve activity in hypertensive patients Evaluation of different class effect of calcium channel blocker by using muscle sympathetic nerve activity - Evaluation of sympathetic nerve activity in hypertensive patients, taking hypotensive drugs, azelnidipine or amlodipine, by using muscle sympathetic nerve activity

Internal Medicine, Kanazawa University Hospital Disease Control and Homeostasis0 个研究点目标入组 20 人开始时间: 2012年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who need drug medication for diabetes mellitus, heart failure or arrhythmia 2.Patients who have severe functional disturbance of liver or kidney 3.Patiens who have history of apoplexy or undergoing operation with artificial vessel 4.Patients of secondary hypertension 5.Patients whose systolic blood pressure is over 200mmHg or diastolic blood pressure is over 120mmHg

研究者

发起方
Internal Medicine, Kanazawa University Hospital Disease Control and Homeostasis

相似试验